Adma Biologics (ADMA) Depreciation and Depletion (2018 - 2020)
Adma Biologics' (ADMA) quarterly Depreciation and Depletion came in at $900000.0 in Q3 2020, up 50.0% YoY from $600000.0 in Q4 2019, and up 50.0% on a QoQ basis from $600000.0 in Q1 2020.
Adma Biologics (ADMA) Depreciation and Depletion (2018 - 2020) Analysis & Trends
Adma Biologics (ADMA) has 3 years of Depreciation and Depletion data on file, last reported at $900000.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.10 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 38.91 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 3.18 Mn |
| 10 | Adma Biologics | 2.13 Bn | 2.00 Bn | 86.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 900,000.00 |
| Sep 30, 2020 | 900,000.00 |
| Mar 31, 2020 | 600,000.00 |
| Mar 31, 2020 | 600,000.00 |
| Sep 30, 2019 | 600,000.00 |
| Sep 30, 2019 | 600,000.00 |
| Jun 30, 2019 | 600,000.00 |
| Jun 30, 2019 | 600,000.00 |
| Mar 31, 2019 | 600,000.00 |
| Mar 31, 2019 | 600,000.00 |
| Sep 30, 2018 | 600,000.00 |
| Sep 30, 2018 | 600,000.00 |
| Jun 30, 2018 | 600,000.00 |
| Jun 30, 2018 | 600,000.00 |
| Mar 31, 2018 | 600,000.00 |
| Mar 31, 2018 | 600,000.00 |